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and a new congener from fuscol†
Alexander R. Rovira, a Nicolas Mu¨ller, a Weiwen Deng,b Chudi Ndubakub
and Richmond Sarpong *a
The xishacorene natural products are structurally unique apolar diterpenoids that feature a bicyclo[3.3.1]
framework. These secondary metabolites likely arise from the well-studied, structurally related
diterpenoid fuscol. In this manuscript, we describe the conversion of fuscol to xishacorenes A, B, and C,
as well as a previously unreported congener, which we have named xishacorene D. In addition, we
describe immunomodulatory activity studies of the xishacorenes, a structurally related analogue, and
fuscol. These studies were aided by an accurate determination of the physical properties (e.g., molar
extinction coefficient) of the highly apolar xishacorenes.Introduction
Polyene cyclizations are among the most powerful methods for
the rapid construction of C–C bonds in carbon-based frame-
works. These cyclizations, which appear in the biosyntheses of
a wide array of topologically complex natural products, oen
proceed through concerted, stereocontrolled pathways.1 Of the
natural products formed through polyene cyclizations, terpene-
derived secondary metabolites (terpenoids) are among the most
studied. While the biosynthetic pathways that lead to many
terpenoid molecules have formed the basis for their chemical
syntheses, synthetic endeavors toward terpenoids that exploit
polyene cyclizations can provide insights into the role of these
reactions in their biosynthesis as well.2
The xishacorene diterpenoids (see 1–3, Fig. 1), were isolated
in 2017 from the so coral Sinularia polydactyla off the coast of
the Xisha Islands in the South China Sea.3 These secondary
metabolites were obtained alongside a structurally-related
terpenoid, fuscol (5), from which 1–3 are proposed to arise
through an acid-mediated polyene cyclization (Fig. 1).3 Fuscol
was rst isolated in 1978 by Schmitz and coworkers.4 In
considering the biogenesis of the xishacorenes, fuscol appears
to be the likely progenitor. However, the link between these
natural products has not been realized in a laboratory setting.5
Furthermore, as outlined by the cyclization sequence illus-
trated in Fig. 1, one would have expected the isolation of
compound 4, a diastereomer of 3, which we have named
“xishacorene D”, alongside the other xishacorene congeners.ifornia, Berkeley, California 94720, USA.
y, California 94720, USA
tion (ESI) available. See DOI:Evidence that the xishacorenes can arise from fuscol would
provide key support for a unied biosynthesis of these natural
products from geranylgeranyl pyrophosphate (GGPP, 8), as it
has been shown that 5 can arise from eunicol (6) through
a Cope rearrangement.6
Fuscol and its glycosylated derivatives (e.g., fuscoside B, 8,
Fig. 2A) possess signicant anti-inammatory activity.7 Given
their putative biosynthetic connections, analogous activity
might be anticipated for the xishacorenes. A preliminary bio-
logical screening of 1–3 by Guo et al. revealed that these mole-
cules possess notable activity as promoters of concavalin A
(ConA)-induced T-lymphocyte proliferation.3 This observed
activity supports a possible link between fuscol and the xisha-
corenes as immune modulators.8 However, the capacity of the
xishacorenes to act as antagonists of immunological pathways
has not previously been studied.9
In 2018, we reported the rst total synthesis of xishacorene B
from R-()-carvone as part of a program aimed at the synthesis
of structurally complex molecules from inexpensive “chiral
pool” precursors.10,11 While our synthetic plan provided access
to 2, it was not easily extended to the syntheses of the other
xishacorenes, especially 3, which possesses an exo methylene
group that would be difficult to install using our previously re-
ported approach. It has been recognized that fuscol, which has
been synthesized by several groups,12 could serve as a precursor
to all xishacorene congeners. Access to the xishacorenes from
fuscol would not only provide support for their proposed
biosynthesis, but also facilitate further investigations into their
bioactivity.
Herein, we report a preparation of the known xishacorenes
(i.e., A–C; 1–3) and the previously unreported congener xisha-
corene D (4), along with a fuscol-like analog (10, Fig. 2B).
Furthermore, we provide revised physical data for the xisha-
corene natural products and biological assays of 1–5 and 10.This journal is © The Royal Society of Chemistry 2019
Fig. 1 Proposed biosynthesis of the xishacorene family from GGPP.
Fig. 2 (A) Structure of fuscoside B; (B) Fuscol analogue 10 synthesis;
(C) Alkyne-arabinose 11. Conditions: (a)m-CPBA, DCM, 0 C, 2 h (80%
yield); (b) LiAlH4, THF, 0 C, 4 h (87% yield).
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View Article OnlineResults and discussion
Synthesis of analogues of the xishacorenes
Our studies that led to the preparation of all the xishacorenes
commenced with an initial goal of obtaining a library of gly-
cosylated derivatives of fuscol and xishacorene B for biological
screenings. For this purpose, we synthesized a hydroxylated
xishacorene B-derived analogue of fuscol (10, Fig. 2B) starting
from 2, which we had previously prepared.11 Epoxidation of 2
with m-CPBA gave epoxide 9 as a mixture of diastereomers,
which upon reduction with LiAlH4 yielded tertiary alcohol 10
(70% yield over two steps). With 10 in hand, we then sought to
prepare fuscoside B (8), which would enable us to test the
glycosylation of these tertiary alcohols including 10. While there
have been several attempts to prepare the fuscosides,13 only the
undesired b-anomer of 8 has been synthesized in low yield. We
posited that modern glycosylation strategies, such as those
developed by Yu et al.,14 using gold catalysis with an alkyne
glycoside donor (e.g. 11, Fig. 2C), would enable mild, relatively
neutral glycosylation conditions to access 8.15 The fuscol (5)
required for these studies was prepared in 14 steps from S-
()-verbenone by adapting the synthetic procedures reported by
Kato et al.12aThis journal is © The Royal Society of Chemistry 2019An unexpected cyclization of fuscol
Upon treatment of 5 with glycoside 11 at 23 C using the stan-
dard Yu glycosylation conditions (Table 1, entry 1), we observed
a complex mixture of products, which co-eluted as a single,
apolar band by normal-phase chromatography. Using reversed-
phase chromatography, we unexpectedly isolated small quan-
tities of the xishacorenes along with several unidentiable
decomposition products. Upon lowering the reaction tempera-
ture to 20 C, xishacorenes A–C (1, 2, and 3), as well as the
previously unreported diastereomer 4, were isolated (Table 1,
entry 2) in appreciable yields, with 3 as the major product.
Following the screening of various acid conditions (Table 1,
entries 5–10), we found the use of BF3$OEt2 at 78 C to be
optimal, giving the xishacorenes in a combined 49% isolated
yield aer 15 minutes (Table 1, entry 8). Intriguingly, cyclization
was not observed using the triimide gold complex in the
absence of glycoside 11,16 nor did the desired cyclization occur
with bis(triuoromethane)sulfonimide (Tf2NH) alone.17Analysis of the physical properties of the xishacorenes
Following our preparation of 1–4, we sought to verify their re-
ported physical properties. The originally reported molar
extinction coefficient (3) values for each of the xishacorenes
varied signicantly (by factors of 10–20), which was surprising
given their close structural similarity. Likewise, the reported 3
value for xishacorene B is unexpectedly high
(147 910 M1 cm1), and is more characteristic of a highly
conjugated p system.18 As 3 values are particularly important for
the accurate determination of solution concentrations for bio-
logical studies, we remeasured these values in cyclohexane
before pursuing bioactivity assays. We found the corresponding
3 values to equal 9448, 11 145, 18 594, and 9721 M1 cm1 for 1,
2, 3, and 4 respectively. We also measured lmax values for these
compounds and obtained values consistent with what would be
anticipated for these molecules (239–240 nm for 1–4 in cyclo-
hexane).19 We hypothesize that the inconsistencies between the
previously reported values and those we measured may arise
from the insolubility of these secondary metabolites in meth-
anol, which had been used as the solvent in the original report.Chem. Sci., 2019, 10, 7788–7791 | 7789
Table 1 Fuscol cyclization
Entry Conditionsa Yield Ratio (1 : 2 : 3 : 4)
1 11, Ph3PAuNTf2 (20 mol%), 4 A˚ MS, rt Trace —
2 11, Ph3PAuNTf2 (20 mol%), 4 A˚ MS, 20 C 40% 1 : 1 : 2.5 : 1.25
3 11, Ph3PAuNTf2 (20 mol%), 4 A˚ MS, 78 C n.r. —
4 11, (4-CF3C6H4)3PAuCl (20 mol%), 4 A˚ MS, rt n.r. —
5 Ph3PAuNTf2 (20 mol%), 4 A˚ MS, rt n.r. —
6 Tf2NH (20 mol%), rt n.r. —
7 Tf2NH (1 equiv.), 78 C Decomp. —
8 BF3$OEt2 (1 equiv.), 78 C 49% 1.5 : 1 : 3 : 1.5
9 BF3$OEt2 (1 equiv.), Et2O, 78 C Decomp. —
10 SnCl4 (1 equiv.), 78 C Decomp. —
11 Silica, rtb n.r. —
12 TFA, 0 Cb Decomp. —
13 CSA, 0 Cb Decomp. —
a All reactions run in DCM unless otherwise noted. b Previously reported.
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View Article OnlineA lack of complete dissolution of the xishacorenes could explain
the signicant variations of the reported values from those we
measured. Similarly, as noted in our previous report,11 our
measured optical rotation of synthetic xishacorene B differed
from that reported for the naturally isolated material ([a]20D of
11.3 reported, whereas we had found it to be19.5 measured).
We observed similar deviations for 1 and 3 as well and have
provided updated [a]20D values obtained using CHCl3 as the
solvent (see the ESI†).20
Preliminary biological assays
With the revised analytical properties of the xishacorenes
determined, we undertook a series of biological assays to
ascertain their bioactivity. Initial cell viability studies using
THP1-Dual™ reporter cells with each of the assayed
compounds conrmed that the majority of cells survived at 100
mM, whereas we observed dramatic cell death at 1 mM, as
determined by a CellTiter-Glo® assay (Fig. 3A). In order to
determine the immunogenic activity of the xishacorenes, THP-Fig. 3 THP-1 cell assay of compounds 1–5 and 10 after 24 h of
incubation. (A) CellTiter-Glo® assay measure of cell viability at each
concentration. (B) Activity assay of compounds following stimulation
with ML RR-S2 cGAMP (STING Promoter).
7790 | Chem. Sci., 2019, 10, 7788–77911-Dual™ cells featuring a secreted luciferase reporter to
monitor activity of the IRF pathway were used. Each of the
assayed compounds was dissolved in DMSO to create stock
solutions. These solutions were then added to the media prior
to incubation with or without a known STING (stimulator of
interferon genes) agonist (ML RR-S2 cGAMP).21 Aer 24 hours of
incubation, none of the assayed compounds emerged as
antagonists of the IRF pathway, as monitored by luciferase
expression. However, fuscol and hydroxylated xishacorene B
derivative 10 were found to inhibit IRF activity induced by ML
RR-S2 cGAMP (Fig. 3B). These observations suggest that the
hydrophilic nature of fuscol and the fuscol-like analogue, unlike
the highly apolar xishacorenes, is key to potency. Our future
studies will seek to prepare other oxygenated variants of the
xishacorenes that may have enhanced hydrophilicity.Conclusions
In conclusion, we have demonstrated that fuscol undergoes an
acid-mediated cyclization to produce the xishacorenes, supporting
the proposed biosynthesis of this unique family of diterpenoids.
Our isolation of xishacorene D also raises the possibility that this
compound might co-occur alongside the other xishacorene
congeners and may have been missed in the original isolation,
since we obtained xishacorene D in a very small amount from the
cyclization of fuscol. Bioactivity studies of fuscol and the xisha-
corenes, facilitated by a redetermination of the physical properties
of the latter compounds, have provided unique insight into the
importance of hydrophilic substituents to their bioactivity.Conflicts of interest
WD and CN are employees and shareholders of Aduro Biotech,
Inc.This journal is © The Royal Society of Chemistry 2019
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